I assume that Matt and Bill - with all those FDA approved products on their record - know better than most about the FDA trial integrity requirements and that even though the current trials do not require Data Monitoring Committees (DMC), access to data by the sponsor during a trial under the current requirements by the FDA can actually invalidate the whole trial. Are Matt and Bill that irresponsible? I don't think so.
If you're following the current discussion on possible 'leakages' on the trial, you may want to read the following and particularly lines 1046 to 1055:
https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm201790.pdf
https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm127073.pdf
Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received, page-26
-
- There are more pages in this discussion • 172 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.055(16.9%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 38.0¢ | 33.0¢ | $7.103M | 19.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 134000 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 650314 | 19 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |